Concepedia
Statistics
Publications
11
Citations
2K
H-Index
10
Active since
2000
Affiliations
Gilead Sciences (United States)(Current)
Howard Hughes Medical Institute
The University of Texas MD Anderson Cancer Center
University of California, San Francisco
Oregon Health & Science University
Sarah Meadows is an author at Gilead Sciences (United States) specializing in life sciences, oncology, and pharmacology.
Publications per year
2000–2017
CAL-101, a p110δ selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability
Brian J. Lannutti, Sarah Meadows, Sarah E. M. Herman et al. · Blood · 2010 · 718 citations · Full text
Medicine, Oncology, Pharmacology +11
The phosphoinositide 3′-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia
Julia Hoellenriegel, Sarah Meadows, Mariela Sivina et al. · Blood · 2011 · 548 citations · Full text
Life Sciences, Cancer Biology, Oncology +15
Genome-wide study of aging and oxidative stress response in <i>Drosophila</i> <i>melanogaster</i>
Sige Zou, Sarah Meadows, Linda Sharp et al. · Proceedings of the National Academy of Sciences · 2000 · 318 citations · Full text
Life Sciences, Biology, Molecular Biology +17
PI3Kδ inhibitor, GS-1101 (CAL-101), attenuates pathway signaling, induces apoptosis, and overcomes signals from the microenvironment in cellular models of Hodgkin lymphoma
Sarah Meadows, Francisco Vega, Adam Kashishian et al. · Blood · 2011 · 151 citations · Full text
Life Sciences, Cell Biology, Oncology +17
A Gain-of-Function Screen for Genes That Affect the Development of the Drosophila Adult External Sensory Organ
Salim Abdelilah‐Seyfried, Yee-Ming Chan, Chaoyang Zeng et al. · Genetics · 2000 · 104 citations · Full text
Life Sciences, Developmental Biology, Genetics +16
1–5 of 11